Production of urokinase-type plasminogen activator (u-PA) and plasminogen activator inhibitor-1 (PAI-1) in human brain tumours

Acta Neurochirurgica

Volumn 140, Issue 4, 1998, Pages 377-386

  Arai, Y ^a   Kubota, T ^a   Nakagawa, T ^a   Kabuto, M ^a   Sato, K ^a   Kobayashi, H ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

Brain tumour invasion; Plasminogen activator inhibitor I; Plasminogen activators

Indexed keywords

MONOCLONAL ANTIBODY; PLASMINOGEN ACTIVATOR INHIBITOR 1; UROKINASE;

ACOUSTIC NEURINOMA; ADULT; AGED; ARTICLE; BRAIN METASTASIS; BRAIN TUMOR; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLIOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN; BRAIN NEOPLASMS; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; URINARY PLASMINOGEN ACTIVATOR;

EID: 0031803957     PISSN: 00016268     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007010050112     Document Type: Article

References (41)

1. Andreasen PA, Georg B, Lund LR, Riccio A, Stacey SN (1990) Plasminogen activator inhibitors: hormonally regulated serpins. Mol Cell Endocrinol 68: 1-19
2. Bacharach E, Itin A, Keshet E (1992) In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis. Proc Natl Acad Sci USA 89: 10686-10690
3. Berkman RA, Merrill MJ, Reinhold WC, Monacci WT, Saxena A. Clark WC, Robertson JT, Ali IU, Oldfield EH (1993) Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest 91: 153-159
4. Blasi F, Verde P (1990) Urokinase-dependent cell surface proteolysis and cancer. Semi Cancer Biol 1: 117-126
5. Boyd D (1992) Plasminogen-dependent laminin degradation and matrigel invasion by cultured colon cancer is directed by receptor-bound urokinase. Fibrinolysis 6 [Suppl 1]: 17-21
6. Bream S, Tsanaclis AMC, Gately S, Gross JA, Herblin WF (1990) Immunolocalization of basic fibroblast growth factor to the microvasculature of human brain tumors. Cancer 70: 2673-2680
7. Duffy MJ (1991) Plasminogen activators and cancer. Blood Coagul Fibrinol 1: 681-687
8. Gross JL, Moscatelli D, Rifkin DB (1983) Increased capillary endothelial cell protease activity in response to angiogenic stimuli in vitro. Proc Natl Acad Sci USA 80: 2623-2627
9. Grøndahl-Hansen J, Christensen IJ, Rosenquist C, Brünner N, Mouridsen HT, Danø K, Blichert-Toft M (1993) High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis. Cancer Res 53: 2513-2521
10. Guarino M (1993) Immunohistochemistry of Schwann cell markers, intermediate filaments and extracellular matrix components. Pathol Res Pract 189: 913-920
11. Nekarda H, Schmitt M, Ulm K, Wenninger A, Vogelsang H, Becker K, Roder JD, Find U, Siewert JR (1994) Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer. Cancer Res 54: 2900-2907
12. Hollas W, Blasi F, Boyd D (1991) Role of the urokinase receptor in facilitating extracellular matrix invasion by cultured colon cancer. Cancer Res 51: 3690-3695
13. Hsu DW, Efird JT, Hedley-Whyte ET (1995) Prognostic role of plasminogen activator in human gliomas. Am J Pathol 147: 114-123
14. Kalderon N (1990) Glial plasminogen activators in developing and regenerating neural tissue. In: Festoff BW (ed) Serine proteases and their serpin inhibitors in the nervous system. Plenum, New York, pp 209-217.
15. Kono S, Rao JS, Bruner JM, Sawaya R (1994) Immunohistochemical localization of plasminogen activator inhibitor type 1 in human brain tumors. J Neuropathol Exp Neurol 53: 256-262
16. Kubota T, Nakagawa T, Hosotani K, Kabuto M, Arai Y, Sato K. Kawano H (1992) Immunohistochemical study of extracellular matrix in schwannomas: In vivo and in vitro observation. Brain Tumor Pathol 9: 23-31
17. Kwaan HC (1992) The Plasminogen-plasmin system in malignancy. Cancer Met Rev 11: 291-311
18. Laerum OD, Bjerkvig R, Steinsvag SK, de Ridder L (1984) Invasiveness of primary brain tumors. Cancer Met Rev 3: 223-236
19. Landau BJ, Kwaan HC, Verrusio EN, Brem SS (1994) Elevated levels of urokinase-type plasminogen activator and plasminogen activator inhibitor type-1 in malignant human brain tumors. Cancer Res 54: 1105-1108
20. Liu G, Shuman MA, Cohen RL (1995) Co-expression of urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells. Int J Cancer 60: 501-506
21. Liotta LA, Steeg PS, Stetler-Stevenson WG (1991) Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 64: 327-336
22. Matsunaga T, Kanzaki J, Hosoda Y (1996) Angiogenesis from the eighth cranial nerve to vestibular schwannomas. Acta Otolaryngol Stockh 116: 52-58
23. Mignatti P, Robbins E, Rifkin DB (1986) Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell 47: 487-498
24. Montesano R, Pepper MS, Möhle-Steinlein U, Risau W, Wagner EF, Orci L (1990) Increased proteolytic activity is responsible for the aberrant morphogenic behavior of endothelial cells expressing the middle T oncogene. Cell 62: 435-445
25. Moscatelli D, Rifkin DB (1988) Membrane and matrix localization of proteinases: a common themein tumor cell invasion and angiogenesis. Biochem Biophys Acta 948: 67-85
26. Nakagawa T, Kubota T, Kabuto M, Sato K, Kawano H, Hayakawa T, Okada Y (1994) Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J Neurosurg 81: 69-77
27. Ossowski L, Reich E (1983) Antibodies to plasminogen activator inhibit tumor metastasis. Cell 35: 611-619
28. Peper MS, Ferrara N, Orci L, Montesano R (1991) Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelical cells. Biochem Biophys Res Commun 181: 902-906
29. Plate KH, Brier G, Weich HA, Risau W (1992) Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature (Lond) 359: 845-848
30. Ramshaw IA, Badenoch-Jones P, Grant A, Maxted M, Claudianos C (1986) Enhanced plasminogen activator production by highly metastatic variant cells of a rat mammary adenocarcinoma. Invasion Metastasis 6: 133-144
31. Reilly D, Christensen L, Duch M, Nolan N, Duffy MJ, Andreasen PA (1992) Type-1 plasminogen activator inhibitor in human breast carcinomas. Int J Cancer 50: 208-214
32. de Ridder L, Calliauw L (1990) Invasion of human brain tumors in vitro: relationship to clinical evolution. J Neurosurg 72: 589-593
33. Rifkin DB, Moscatelli D, Bizik J, Quarto N, Blei F, Dennis P, Flaumenhaft R, Mignatti P (1990) Growth factor control of extracellular proteolysis. Cell Diff Dev 32: 313-318
34. Saksela O, Rifkin DB (1988) Cell-associated plasminogen activation: regulation and physiological functions. Ann Rev Cell Biol 4: 93-126
35. Sawaya R, Rämö J, Shi ML, Mundybur G (1991) Biological significance of tissue plasminogen activator content in brain tumors. J Neurosurg 74: 480-486
36. Sawaya R, Yamamoto M, Rämo OJ, Shi ML, Rayford A, Rao JS (1995) Plasminogen activator inhibitor-1 in brain tumors: relation to malignancy and necrosis. Neurosurgery 36: 375-381
37. S Ganesh, Sier CFM, Griffioen G, Vloedgraven HJM (1994) Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer. Cancer Res 54: 4065-4071
38. Unkeless JC, Tobia A, Ossowski L, Quigley JP, Rifkin DB, Reich E (1973) An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. J Exp Med 137: 85-111
39. Vecchio SD, Stoppelli MP, Carriero MV, Fonti R, Massa O, Li PY, Botti G, Cerra M, D'Aiuto G, Esposito G, Salvatore M (1993) Human urokinase and benign breast tumors by in vitro quantitative autoradiography. Comparison with urokinase levels. Cancer Res 53: 3198-3206
40. Yamamoto M, Sawaya R, Mohanam S, Bindal AK, Bruner JM, Oka K, Rao VH, Tomonaga M, Nicolson GL, Rao JS (1994) Expression and localization of urokinase-type plasminogen activator in human astrocytomas in vivo. Cancer Res 54: 3656-3661
41. Yamamoto M, Sawaya R, Mohanam S, Loskutoff DJ, Bruner JM, Rao VH, Oka K, Tomonaga M, Nicolson GL, Rao JS (1994) Expression and cellular localization of messenger RNA for plasminogen activator inhibitor type 1 in human astrocytomas. Cancer Res 54: 3329-3332